Chimerix, Inc. (CMRX)

[lattices]

This was helpful, mike. I usually do my research over the weekend, and I was only able to glace at the press release and confirm the cash balance (as Dew also kindly posted.) I had/am worried that the company won't reduce overhead to account for the big reductions in trial management.

The value proposition here is overwhelming. It kills me I don't have the capital to buy more -- it's almost not a biotech risk investment here.

Thanks to you and Dew here -- it's useful to have board commentary.